Critical Path Network: CMS extends coverage for some O2 patients
Critical Path Network
CMS extends coverage for some O2 patients
The Centers for Medicare & Medicaid Services (CMS) will extend coverage for the home use of oxygen to Medicare beneficiaries enrolled in a CMS-approved clinical trial sponsored by the National Heart, Lung & Blood Institute.
Medicare currently provides coverage for home oxygen for beneficiaries with partial pressure measurements at or below 55 mmHg or oxygen saturation at or below 88%.
If certain other diseases/conditions are present, coverage is provided for patients with an oxygen partial pressure of 56-60 mmHg or an oxygen saturation of 89%.
The trial will include Medicare beneficiaries with arterial oxygen partial measurements from 56 mmHg to 65 mmHg or whose oxygen saturation is at or above 89% who do not meet the current Medicare coverage requirements for home oxygen.
The Centers for Medicare & Medicaid Services (CMS) will extend coverage for the home use of oxygen to Medicare beneficiaries enrolled in a CMS-approved clinical trial sponsored by the National Heart, Lung & Blood Institute.Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.